Serevent Asthma Safety Signal Is Good News For Advair, GSK Says
Adverse event outcomes from a Serevent safety study could help GlaxoSmithKline in one of its key messages for Advair, CEO J.P. Garnier told analysts in New York City Feb. 13
Adverse event outcomes from a Serevent safety study could help GlaxoSmithKline in one of its key messages for Advair, CEO J.P. Garnier told analysts in New York City Feb. 13